|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
2006-6-12
|
|
pubmed:abstractText |
Atherosclerosis is an inflammatory disease in which a perpetuated activation of NFkappaB via the RAGE (receptor for advanced glycation end products)-MAPK signalling pathway may play an important pathogenetic role. As recently S100 proteins have been identified as ligands of RAGE, we sought to determine the effects of the proinflammatory heterodimer of S100A8/S100A9 on the RAGE-NFkappaB mediated induction of proinflammatory gene expression.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/16573830-10399917,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16573830-10728757,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16573830-11007787,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16573830-11108954,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16573830-11141076,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16573830-11168370,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16573830-11375353,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16573830-11723063,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16573830-11723110,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16573830-11854121,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16573830-11953450,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16573830-12070121,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16573830-12645002,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16573830-12911334,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16573830-12912808,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16573830-14661090,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16573830-14670831,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16573830-15598812,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16573830-16133426,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16573830-2771659,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16573830-3405210,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16573830-3561500,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16573830-4355998,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16573830-6695777,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16573830-7648708,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16573830-7738161,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16573830-8549885,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16573830-8701470,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16573830-9083090,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16573830-9287050,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16573830-9337199,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16573830-9570563,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16573830-9575199,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16573830-9732872,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16573830-9887164,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16573830-9920411
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/CCL2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Calgranulin A,
http://linkedlifedata.com/resource/pubmed/chemical/Calgranulin B,
http://linkedlifedata.com/resource/pubmed/chemical/Chemokine CCL2,
http://linkedlifedata.com/resource/pubmed/chemical/Glycosylation End Products, Advanced,
http://linkedlifedata.com/resource/pubmed/chemical/Intercellular Adhesion Molecule-1,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-6,
http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Cell Adhesion Molecule-1
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1475-2840
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
5
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
6
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:16573830-Calgranulin A,
pubmed-meshheading:16573830-Calgranulin B,
pubmed-meshheading:16573830-Cells, Cultured,
pubmed-meshheading:16573830-Chemokine CCL2,
pubmed-meshheading:16573830-Dimerization,
pubmed-meshheading:16573830-Dose-Response Relationship, Drug,
pubmed-meshheading:16573830-Endothelium, Vascular,
pubmed-meshheading:16573830-Glycosylation End Products, Advanced,
pubmed-meshheading:16573830-Humans,
pubmed-meshheading:16573830-Inflammation,
pubmed-meshheading:16573830-Intercellular Adhesion Molecule-1,
pubmed-meshheading:16573830-Interleukin-6,
pubmed-meshheading:16573830-Mitogen-Activated Protein Kinases,
pubmed-meshheading:16573830-Recombinant Proteins,
pubmed-meshheading:16573830-Umbilical Veins,
pubmed-meshheading:16573830-Vascular Cell Adhesion Molecule-1
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products.
|
|
pubmed:affiliation |
Universität Heidelberg, Abteilung Innere Medizin III, Heidelberg, Germany. philipp.ehlermann@med.uni-heidelberg.de
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
